David H. Dolphin, OC FRS FRSC (born January 15, 1940) is a Canadian biochemist. He is an internationally recognized expert in porphyrin chemistry and biochemistry. He was the lead creator of Visudyne, a medication used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. He is Chief Executive Officer of the BC Innovation Council and Vice-President, Technology Development at Quadra Logic Technologies Incorporated (QLT Inc.).